{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:58:22Z","timestamp":1783767502130,"version":"3.55.0"},"reference-count":27,"publisher":"Georg Thieme Verlag KG","issue":"02","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["PG\/15\/9\/31270"],"award-info":[{"award-number":["PG\/15\/9\/31270"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["FS\/15\/42\/3155"],"award-info":[{"award-number":["FS\/15\/42\/3155"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Individuals with type-1 diabetes mellitus (T1DM) have a higher risk of thrombosis and low plasma magnesium concentrations. As magnesium is a known regulator of fibrin network formation, we investigated potential associations between fibrin clot properties and plasma magnesium concentrations in 45 individuals with T1DM and 47 age- and sex-matched controls without diabetes. Fibrin clot characteristics were assessed using a validated turbidimetric assay and associations with plasma magnesium concentration were examined. Plasma concentrations of fibrinogen, plasminogen activator inhibitor-1 (PAI-1), and lipids were measured and fibrin fiber diameters assessed using scanning electron microscopy. Fibrin clot maximum absorbance was unchanged in subjects with T1DM compared with controls, while lysis time was prolonged (p\u2009=\u20090.0273). No differences in fibrin fiber diameters or in lipid profile were observed between T1DM and controls. PAI-1 concentration was lower in the T1DM group compared with the controls (p\u2009=\u20090.0232) and positively correlated with lysis time (p\u2009=\u20090.0023). Plasma magnesium concentration was lower in the T1DM group compared with controls (p\u2009&lt;\u20090.0001). Magnesium concentration negatively correlated with clot maximum absorbance (p\u2009=\u20090.0215) and lysis time (p\u2009=\u20090.0464). A turbidimetric fibrin clot lysis assay performed in a purified system that included PAI-1 and 0 to 3.2\u2009mM Mg2+ showed a shortening of lysis time with increasing Mg2+ concentrations (p\u2009=\u20090.0004). Our findings reveal that plasma magnesium concentration is associated with changes in fibrin clot and lysis parameters.<\/jats:p>","DOI":"10.1055\/s-0039-3402808","type":"journal-article","created":{"date-parts":[[2020,1,4]],"date-time":"2020-01-04T00:00:36Z","timestamp":1578096036000},"page":"243-252","source":"Crossref","is-referenced-by-count":19,"title":["Reduced Plasma Magnesium Levels in Type-1 Diabetes Associate with Prothrombotic Changes in Fibrin Clotting and Fibrinolysis"],"prefix":"10.1055","volume":"120","author":[{"given":"Am\u00e9lie I. S.","family":"Sobczak","sequence":"additional","affiliation":[{"name":"School of Medicine, University of St Andrews, St Andrews, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fladia A.","family":"Phoenix","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J.","family":"Pitt","sequence":"additional","affiliation":[{"name":"School of Medicine, University of St Andrews, St Andrews, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramzi A.","family":"Ajjan","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4580-1840","authenticated-orcid":false,"given":"Alan J.","family":"Stewart","sequence":"additional","affiliation":[{"name":"School of Medicine, University of St Andrews, St Andrews, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"9041694","DOI":"10.1155\/2018\/9041694","article-title":"Magnesium and human health: perspectives and research directions","volume":"2018","author":"A M Al Alawi","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2337\/diacare.23.10.1516","article-title":"Incidence of childhood type 1 diabetes worldwide. Diabetes mondiale (DiaMond) project group","volume":"23","author":"M Karvonen","year":"2000","journal-title":"Diabetes Care"},{"issue":"03","key":"ref3","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s13300-019-0612-8","article-title":"Cardiovascular risk in type 1 diabetes mellitus","volume":"10","author":"J Schofield","year":"2019","journal-title":"Diabetes Ther"},{"issue":"03","key":"ref4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S2213-8587(14)70248-7","article-title":"Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis","volume":"3","author":"R R Huxley","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"15","key":"ref5","doi-asserted-by":"crossref","first-page":"8541","DOI":"10.1074\/jbc.271.15.8541","article-title":"Magnesium(II) is a crucial constituent of the blood coagulation cascade. Potentiation of coagulant activities of factor IX by Mg2+ ions","volume":"271","author":"F Sekiya","year":"1996","journal-title":"J Biol Chem"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00012.2014","article-title":"Magnesium in man: implications for health and disease","volume":"95","author":"J H de Baaij","year":"2015","journal-title":"Physiol Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0140-6736(59)92002-1","article-title":"The effect of magnesium on blood coagulation in human subjects","volume":"1","author":"H B Anstall","year":"1959","journal-title":"Lancet"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ajcp\/aqw066","article-title":"Magnesium sulfate as an alternative in vitro anticoagulant for the measurement of platelet parameters?","volume":"145","author":"S Mannu\u00df","year":"2016","journal-title":"Am J Clin Pathol"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10534-018-00167-z","article-title":"Total plasma magnesium, zinc, copper and selenium concentrations in type-I and type-II diabetes","volume":"32","author":"A IS Sobczak","year":"2019","journal-title":"Biometals"},{"issue":"04","key":"ref10","first-page":"147","article-title":"Hypomagnesemia and cardiovascular system","volume":"10","author":"G Efstratiadis","year":"2006","journal-title":"Hippokratia"},{"issue":"03","key":"ref11","first-page":"155","article-title":"Changes in the haemostatic profile during magnesium deficiency in swine","volume":"9","author":"V L Serebruany","year":"1996","journal-title":"Magnes Res"},{"issue":"08","key":"ref12","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/j.1538-7836.2010.03910.x","article-title":"Hyperglycemia: a prothrombotic factor?","volume":"8","author":"B A Lemkes","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref13","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1210\/jc.2011-2894","article-title":"Thyroid dysfunction and fibrin network structure: a mechanism for increased thrombotic risk in hyperthyroid individuals","volume":"97","author":"J M Hooper","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"04","key":"ref14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00125-011-2301-7","article-title":"A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3","volume":"55","author":"K Hess","year":"2012","journal-title":"Diabetologia"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1172\/JCI115384","article-title":"Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans","volume":"88","author":"P De Feo","year":"1991","journal-title":"J Clin Invest"},{"issue":"07","key":"ref16","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2337\/dc13-1776","article-title":"Increased incorporation of antiplasmin into the fibrin network in patients with type 1 diabetes","volume":"37","author":"A Agren","year":"2014","journal-title":"Diabetes Care"},{"issue":"02","key":"ref17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1160\/TH14-05-0404","article-title":"Fibrin clot properties and haemostatic function in men and women with type 1 diabetes","volume":"113","author":"S Tehrani","year":"2015","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jdiacomp.2014.01.011","article-title":"Plasminogen activator inhibitor-1 (PAI-1) in children and adolescents with type 1 diabetes mellitus: relation to diabetic micro-vascular complications and carotid intima media thickness","volume":"28","author":"A A Adly","year":"2014","journal-title":"J Diabetes Complications"},{"issue":"08","key":"ref19","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1111\/j.1538-7836.2005.01420.x","article-title":"PAI-1 and atherothrombosis","volume":"3","author":"D E Vaughan","year":"2005","journal-title":"J Thromb Haemost"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.2741\/2285","article-title":"Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis","volume":"12","author":"Y Aso","year":"2007","journal-title":"Front Biosci"},{"issue":"01","key":"ref21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.transci.2007.12.005","article-title":"Thrombin generation, fibrin clot formation and hemostasis","volume":"38","author":"A S Wolberg","year":"2008","journal-title":"Transfus Apheresis Sci"},{"issue":"02","key":"ref22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5114\/ceji.2013.35203","article-title":"Complex function of magnesium in blood clot formation and lysis","volume":"38","author":"J Jankun","year":"2013","journal-title":"Cent Eur J Immunol"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/jmr.1101","article-title":"Physiologically relevant divalent cations modulate citrate recognition by the McpS chemoreceptor","volume":"24","author":"J Lacal","year":"2011","journal-title":"J Mol Recognit"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00001721-200201000-00003","article-title":"Magnesium and manganese ions accelerate tissue factor-induced coagulation independently of factor IX","volume":"13","author":"A M van den Besselaar","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"06","key":"ref25","doi-asserted-by":"crossref","first-page":"e0157835","DOI":"10.1371\/journal.pone.0157835","article-title":"Exogenous magnesium chloride reduces the activated partial thromboplastin times of lupus anticoagulant-positive patients","volume":"11","author":"T Tokutake","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jmb.2013.02.017","article-title":"Structural and functional studies of \u03b3-carboxyglutamic acid domains of factor VIIa and activated protein C: role of magnesium at physiological calcium","volume":"425","author":"K Vadivel","year":"2013","journal-title":"J Mol Biol"},{"issue":"04","key":"ref27","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2337\/dc07-2124","article-title":"Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects","volume":"31","author":"A Juutilainen","year":"2008","journal-title":"Diabetes Care"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0039-3402808.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T11:14:11Z","timestamp":1730805251000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0039-3402808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":27,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2020,2,2]]},"published-print":{"date-parts":[[2020,2]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0039-3402808","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,3]]}}}